Bradley Merrill Thompson, a Member of the Firm in the Health Care and Life Sciences practice, in the Washington, DC, office, wrote an article titled "After FDA's Mobile Medical Apps Final Guidance, What's Next?"
Following is an excerpt:
Bradley Merrill Thompson, a Member of the Firm in the Health Care and Life Sciences practice, in the Washington, DC, office, wrote an article titled "After FDA's Mobile Medical Apps Final Guidance, What's Next?"
Following is an excerpt: